Larry Witte
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 6
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 6
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 8
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 8
- Lymphatic System and Diseases 6
- Molecular Biology top 0.5%
- Angiogenesis and VEGF in Cancer 32
- Glycosylation and Glycoproteins Research 13
-
- Monoclonal and Polyclonal Antibodies Research 18
- Co-authors
- Zhenping ZhuDaniel J. HicklinShahin RafiiMalcolm A.S. MooreSérgio DiasPeter BöhlenKoichi HattoriBeate Heissig
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Larry Witte
67 papers receiving 10.8k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Hematology 2.1k
- Genetics 1.8k
- Cancer Research 2.5k
- Oncology 3.5k
- Molecular Biology 7.5k
Countries citing papers authored by Larry Witte
This map shows the geographic impact of Larry Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Witte more than expected).
Fields of papers citing papers by Larry Witte
This network shows the impact of papers produced by Larry Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Witte. The network helps show where Larry Witte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Larry Witte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 40 | |
| 2 | 2008 | 21 | |
| 3 | 2008 | 347 | |
| 4 | 2007 | 184 | |
| 5 | 2006 | 154 | |
| 6 | Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models | 2004 | 13 |
| 7 | Identification and characterization of a fully human antibody directed against epidermal growth factor receptor for cancer therapy | 2004 | 14 |
| 8 | 2004 | 94 | |
| 9 | 2004 | 98 | |
| 10 | 2004 | 27 | |
| 11 | 2003 | 156 | |
| 12 | 2002 | 27 | |
| 13 | Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthbreakdown → | 2001 | 1479 |
| 14 | 2001 | 58 | |
| 15 | 2000 | 59 | |
| 16 | 1999 | 1 | |
| 17 | 1999 | 157 | |
| 18 | 1999 | 29 | |
| 19 | 1998 | 262 | |
| 20 | 1989 | 29 |
About Larry Witte
Larry Witte is a scholar working on Oncology, Genetics, Hematology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 68 papers that have together received 11.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (32 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (13 papers), HER2/EGFR in Cancer Research (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Lymphatic System and Diseases (6 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (1.8k citations), Cancer Research (2.5k citations), Oncology (3.5k citations) and Molecular Biology (7.5k citations). Larry Witte has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Zhenping Zhu, Daniel J. Hicklin, Shahin Rafii, Malcolm A.S. Moore, Sérgio Dias, Peter Böhlen, Koichi Hattori, Beate Heissig, Yan Wu and William J. Lane. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Blood, Nature Medicine and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.